SUMMARY-Buffalo male and female rats 5, 8, 12, 24, 52, and 76 weeks old, with hepatic lesions induced by carbon tetrachloride, were fed 3-methylcholanthrene to study the effect on hepatic lesions induced by CCI 4 • This chemical increased the incidence of hyperplastic nodules and small hepatocellular carcinomas in animals of all ages. The difference was greater in animals 12 weeks of age and older. Females were more susceptible to the development of hyperplastic nodules and carcinomas than were males. Multiple nodules and carcinomas were observed in the livers of animals given both chemicals, whereas animals receiving CCI, had fewer lesions per liver. Cirrhosis of the liver was more advanced in the animals given methylcholanthrene and carbon tetrachloride simultaneously.-J Nat Cancer Inlt 45: 1237-1242, 1970.
control groups of 6 rats of each age and sex were fed only the basal diet of laboratory meal.
The laboratory meal was ingested ad libitum. At a dosage of 1.3 mljkg body weight, carbon tetrachloride was injected subcutaneously twice weekly; 0.033% MCA was added to the meal.
Animals given CC1! and MCA simultaneously were killed when moribund or at the end of 12 weeks. Animals given CCl. only were killed between 6 and 12 weeks to correspond to the time of death for those receiving CCI! and MCA. Rats receiving MCA only, as well as control rats, were killed at the end of 12 weeks. Complete autopsies were done and tissues were fixed in 4% formaldehyde solution. Paraplast sections were stained with hematoxylin and eosin. Sections of liver were also stained with periodic acid-Schiff for glycogen and mucin, Masson trichrome for connective tissue, acid-fast and oil red 0 for ceroid, phosphotungstic acid-hematoxylin for canaliculi and fibrin, Perls' for hemosiderin, Hall's for bilirubin, and Wilder's for reticulum. Oil red 0 staining for lipid was done on frozen sections.
For evaluation of the findings in the livers of each experimental animal, the lesions were classified and tabulated as follows: 1) no hyperplasia, 2) hyperplasia, 3) hyperplastic nodules, 4) small hepatocellular carcinomas (4). Well-developed hepatocellular carcinomas like those seen in animals given other chemical carcinogens were not observed. These lesions were detailed and illustrated by photomicrographs in (1, 4) .
RESULTS
The number of experimental animals with each type of lesion is shown in text-figures 1 and 2. Hepatic lesions or lesions in other organs were not observed in the control animals.
The animals given both CCI! and MCA lost weight, whereas those given only CCI. or MCA gained weight. Terminally, the male rats receiving both chemicals weighed 45-100 g less than those given CCI 4 ; the females, 20-55 g less. The controls and the animals ingesting MCA gained more weight than those on CC1 •.
The male rats of all ages treated with CCI. and MCA survived an average of 9.2 weeks (range, 5.7-12), and the females, an average of 11.0 weeks (range, 6.2-12). Survival times of animals receiving CCl, were similar because of the experimental procedure. Animals fed MCA and the controls lived for 12 weeks.
Male Animals
Hyperplastic nodules were observed in rats 8, 24, and 52 weeks of age given CCI. only. There was one small hepatocellular carcinoma in an 8-week-old animal. Hyperplastic nodules were induced by MCA and CCI. in animals of all ages. Carcinomas were present in rats 12 weeks of age and older. The incidence of nodules and carcinomas increased with increasing age of the rats, with one exception. Curiously, the incidence of nodules and carcinomas was lower in the 8-week-old male rats given both chemicals than in those treated with CCl. alone. In animals of all other ages receiving both chemicals, there were more nodules and carcinomas per liver. This number increased with the age of the animals.
Female Animals
The incidence of hyperplastic nodules in female animals 12-52 weeks old that received CCl. only was greater than in male rats. Females 24 and 52 weeks of age developed the highest incidence of nodules. In comparison to the 5-, 8-, and 12-weekold rats, 76-week-old females were less prone to develop nodules. Males 8 weeks old were more susceptible to the growth of nodules and carcinomas than were females of the same age. One 24-week-old and another 52-week-old animal had small carcinomas.
Nodules and small hepatocellular carcinomas increased notably in females 24, 52 and 76 weeks of age that were treated with CCI, and MCA simultaneously. Almost all rats 52 and 76 weeks old had nodules or carcinomas of the liver. The increase in number of nodules and carcinomas per liver was even more striking in the females than in the males.
Female rats of all ages were more susceptible to the development of hyperplastic nodules and small carcinomas than were male rats. This was evident for animals given CCl. only (except for 8-week-old males), or CCl. and MCA, though the findings were more notable in the latter groups of animals.
Other Hepatic Lesions
Animals given injections of CCl 4 only had mild or moderate cirrhosis. Those fed MCA in the diet simultaneously with injections of CC1 4 developed severe cirrhosis (5,6). The incidence of hepatic vein thrombosis was markedly increased in the rats given both chemicals, except for both males and females 8 weeks of age (6,7). Complete occlusion with infarcts of the liver was observed in three animals: one 5-week-old male and one 24-week-old and one 52-week-old female. Cholangiofibrosis was increased in 5-week-old males and 24-week-old females treated with both chemicals.
Lesions in Organs Other Than liver
The spleen was considerably enlarged in rats given both CCl 4 and MCA, particularly in 5-and 12-week-old animals of both se){es. There was focal or mild, diffuse fibrosis.
Testes, seminal vesicles, and prostate glail.ds were more atrophied in animals with severe cirrhosis, i.e., animals receiving both chemicals. The pancreas was edmatous in rats with ascites.
Fibrin thrombi were present in the left ventricle in one 5-week-old and two 12-week-old females and in the splenic artery in one 5-week-old female and one 24-week-old male. There were focal renal
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n. n. n. infarcts in one 12-week-old female and infarction of the entire kidney in two 12-week-old females. Thyroiditis in rats ingesting MCA in the diet or receiving CCI. was detailed in (8, 9) . The incidence of thyroiditis in animals given both chemicals was similar to that of animals fed MCA only in the diet.
There was a transitional cell carcinoma of the urinary bladder in one 8-week-old female rat receiving both chemicals (5).
DISCUSSION
MCA decreases the incidence of carcinomas of the liver in rats given 3'-methyl-4-dimethylaminoazo-TEXT-FIGURE 2.-Lesions in each animal for each age at the beginning of the experiment. Explanation of bars same as in text-figure 1. (6, 11) . The incidence of carcinomas of the liver is markedly reduced in rats given MCA and diethylnitrosamine simultaneously (6); however, it is only slightly decreased in rats receiving MCA and dimethylnitrosamine (J2). Contrary to these previous reports, MCA, in this experiment, increased the incidence of hyperplastic nodules and small carcinomas of the liver in rats given CCI •.
The hyperplastic hepatic nodules are generally accepted as being preneoplastic (4) . The nodules, as well as the cirrhosis, developed rapidly and the animals died as a result of the cirrhosis. It was shown previously that animals given CCI, must survive for a longer period for the hyperplastic nodules and small carcinomas to become larger, well-developed hepatocellular carcinomas (13) . The severity of the cirrhosis is related to the dosage of MCA and CCI 4 • Smaller dosages are being administered so that the animals will live longer. Also, the chemicals are being discontinued, and the animals allowed to live longer. Earlier studies, with one exception, concerned with hepatic carcinogenesis and MCA did not evaluate the importance of cirrhosis (10) (11) (12) . MCA not only protected against hepatic carcinogenesis, but also against the development of cirrhosis of the liver in rats ingesting 2~FdiAA (6) . In the present work, not only was the incidence of hyperplastic and early neoplastic lesions of the liver increased, but the severity of the cirrhosis also was enhanced. The significance of cirrhosis in the development of hepatocellular carcinomas in experimental animals has not been clarified.
The mechanism by which MCA protects against hepatic carcinogenesis induced by 3' -Me-DAB or 2-FAA has been studied. MCA increases the activity of the enzymes concerned with the hydroxylation of aromatic amines and the reduction of azo bond linkage and the N-demethylation of amino azo dyes (14, 15) .
MCA and CCl 4 both affect the liver. CCl 4 causes intracellular accumulation of lipid (16) (17) (18) (19) (20) , disturbances in protein synthesis and other enzymes of the endoplasmic reticulum (19, 21, 22) , failure of energy synthesis by mitochondria (17, 23) , and necrosis of parenchymal cells (16) . MCA increases amino acid incorporating activity, protein synthesis, and total protein and acts as an effective inducer of microsomal enzymes (24) (25) (26) (27) (28) (29) .
The microsomal enzymes are involved in metabolic detoxication. The metabolism of 3' -Me-DAB or 2-F AA by microsomal enzymes leads to inactive products. Metabolism of CCl 4 is the activation step that leads to its toxicity.
McLean et al. (30) reported that phenobarbitone in the drinking water increased the severity of CCl 4 -induced cirrhosis of the liver. Marshall and McLean (31, 32) showed that phenobarbitone VOL. 45, NO. 6, DECEMBER 1970 increased the amount of cytochrome P-450 in rat liver. The higher level of cytochrome P-450 increased the metabolism of CCl 4 and caused severe cirrhosis in animals given both chemicals. CCl 4 also decreased markedly the amount of this pigment in the hepatic microsomes (33) .
With most potent hepatic carcinogens, MCA is protective; however, it increases the action of the weaker hepatic carcinogen, CCI 4 , and also adds to the severity of the cirrhosis of the liver. It is not clear whether the effects of MCA on CCI, carcinogenesis are related to the increased severity of the cirrhosis and the increased development of hyperplastic nodules, or whether both are important.
